Sudheer Kumar Vuyyuru retweeted
Development and external validation of an endoscopic and histologic pouchitis assessment tool: the Atlantic Pouchitis Index
Congrats to @RocioSedanoMD for leading this over the last 5 years and to all collaborators for their guidance and input. pubmed.ncbi.nlm.nih.gov/4067…
Sudheer Kumar Vuyyuru retweeted
Available online from today, the latest @BritSocGastro IBD guidelines. Thank you to all who contributed. gut.bmj.com/content/74/Suppl…
Sudheer Kumar Vuyyuru retweeted
Replying to @BritSocGastro
@BritSocGastro IBD Guidelines 2025 - out now! : gut.bmj.com/content/74/Suppl…
Sudheer Kumar Vuyyuru retweeted
An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease. Much needed effort to standardize the approach to steroids in trials lead by @ChrisMa_YYC with global contributions! pubmed.ncbi.nlm.nih.gov/4044…
Sudheer Kumar Vuyyuru retweeted
Department of Medicine Residents Research Day. This year we had 95 abstracts from our trainees sharing their research from basic science, clinical research, QI and education research. Thanks to all of our trainees and faculty who made this a success @SchulichMedDent @WesternU
Sudheer Kumar Vuyyuru retweeted
📢 Join us on Tuesday, May 20th at 1:00 PM CET for another exclusive IBUS SciCom Webinar on "Standardized IUS Scoring in IBD" with Dr. Gabriele Dragoni, Dr. Chris Ma and Dr. Christoph Teichert
👉 Visit the IBUS website for more details and to register: ibus-group.org/event/webinar…
Sudheer Kumar Vuyyuru retweeted
💥Our latest on how AI is revolutionizing IBD CTs!💥 AI is boosting patient recruitment, trial efficiency, personalized ttm, endpoint assessment & tackling key ethical & reg challenges👇@vipuljairath @virgisolitano @chrisma_yyc @olga_nardone @IBDologist journals.sagepub.com/doi/10.…
Sudheer Kumar Vuyyuru retweeted
"Unable To Accept...": Leading Industrialists Remember #RatanTata
🖇️ ndtv.com/india-news/ratan-ta…
Sudheer Kumar Vuyyuru retweeted
Tough cases in IBD - spirited discussion from our expert panel. @IBDMD @SeowCynthia @MatthieuAllez @vipuljairath @guthealthmd @ScopeCanMD
Sudheer Kumar Vuyyuru retweeted
How often during a colonoscopy in a patient w #CD could we have missed lesions that would have led to a change in therapy?
I’ve wondered about this many times @virgisolitano addresses it in her 📄
🔍 22.3% had lesions proximal to the TI
🔍 24.5% SB skip lesions in the ileum
🔍 10.4% had strictures
@vipuljairath @IBDJournals
academic.oup.com/ibdjournal/…
Sudheer Kumar Vuyyuru retweeted
New in UEG Journal
🆕 Prevalence of Complications in IBD Detected by Cross-Sectional Imaging
✴️ 33.2% stricturing complications in CD patients.
📊 10.6% fistulizing complications in CD patients.
✴️ Imaging identified EIMs in 7.4% of IBD patients.
🔗 doi.org/10.1002/ueg2.12635
Sudheer Kumar Vuyyuru retweeted
The first #IBUS Regional Hybrid Module 1 Workshop in London was a great success. Thank you to all participants and faculty members for your contribution!
Here is a recap of Day 2.
#IUS #Ultrasound #Workshop
Sudheer Kumar Vuyyuru retweeted
Differential efficacy of medical therapies for ulcerative colitis according to disease extent: patient-level analysis from multiple RCTs
The findings underscore possibility of differential efficacy of medical therapies according to disease distribution
thelancet.com/journals/eclin…
Sudheer Kumar Vuyyuru retweeted
Patients with evidence of microplastics and nanoplastics in carotid artery plaque, as compared with patients without, had a greater risk of adverse cardiovascular events at 34 months of follow-up. Read the full article: nej.md/3IrM6T8
Sudheer Kumar Vuyyuru retweeted
Early-life diet and risk of inflammatory bowel disease: a pooled study in two Scandinavian birth cohorts
gut.bmj.com/content/early/20…
Sudheer Kumar Vuyyuru retweeted
🔊🔥Hot off the press
@AmerGastroAssn #CPU on Role of Diet 🍽️ 🥘 🥗🍔 in #IBD in @AGA_Gastro
✅Mediterranean diet unless contraindicated
💎Personalization is 🔑
🌟Malnutrition not = to low albumin
@JamesLewisGIEpi @BinionMd @AndrewWangMD #jelkins
gastrojournal.org/article/S0…
Sudheer Kumar Vuyyuru retweeted
Excited for the opportunity to work on this. Looking forward to working with our many partners. Thank you to all for the encouragement and wishes. Now the work begins!
@SchulichMedDent @VPRWesternU @WesternU @LHSCCanada @ClevelandClinic
Replying to @IBD_FloMD @HelmsleyTrust @MRegueiroMD @HolubarStefan @tinahamd @DrsMeena @HorstIBDDoc @MLongMD @vipuljairath @propelacure @KatieFalloonMD @SuhaAbushamma @IBD_GorenMD @ScottRSteeleMD @beridgeway @DavidBruiningMD @alimentiv @RitaRys1 @IBD_Sir @tqaziMD @GIdietitian @ManuelBragaMD @CCLRI @IBDBen @ibddoctor @Mud_Fud @AnjaMD_IBD @Y_ECCO_IBD @ibdtweets @AmerGastroAssn @ibddocmaria @WOCNSociety @Ostomy @OstomyCanada @ostomydiaries @ostomyadventure @ownyourcrohns @CrohnsColitisFn @crohnsfighting @BettenworthDb @IBDpartner
👉🏿Grateful to be able to lead this together with @vipuljairath and local collaborators at @CCLRI @ClevelandClinic @WesternU and multiple participating sites. Thank you again to @HelmsleyTrust for enabling us to support our #IBD patients @MRegueiroMD @MichelleKimMD @EdBarnesMD
Sudheer Kumar Vuyyuru retweeted
Check out our “Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study”
@silvio_silvio75 @PeyrinBiroulet
@vipuljairath
sciencedirect.com/science/ar…
Sudheer Kumar Vuyyuru retweeted
Blown away by the science presented by GI and IBD fellows @aiims_newdelhi under stellar mentorship of Dr Vineet Ahuja and colleagues. Diet, FMT, ASUC trials and more, truly bench to bedside. Thank you for having me





































